RELT and cancer: This work provides the first evidence that RELT may sensitize cancer cells to chemotherapeutic agents, especially doxorubicin, although it cannot be excluded that the results shown in Figure 6 are solely from an additive effect of the pro-apoptotic effects of RELT and either taxol or doxorubicin.